Division of Medicine

Publications (original articles or review articles) published in 2009 from OUS - Section for Preventive Cardiology

27 publications found

Abedini S, Holme I, Fellström B, Jardine A, Cole E, Maes B, Holdaas H, ALERT Study Group (2009)
Cerebrovascular events in renal transplant recipients
Transplantation, 87 (1), 112-7
PubMed 19136900

Abedini S, Holme I, März W, Weihrauch G, Fellström B, Jardine A, Cole E, Maes B, Neumayer HH, Grønhagen-Riska C, Ambühl P, Holdaas H, ALERT study group (2009)
Inflammation in renal transplantation
Clin J Am Soc Nephrol, 4 (7), 1246-54
PubMed 19541816

Einvik G, Ekeberg O, Klemsdal TO, Sandvik L, Hjerkinn EM (2009)
Physical distress is associated with cardiovascular events in a high risk population of elderly men
BMC Cardiovasc Disord, 9, 14
PubMed 19331677

Ellingsen I, Seljeflot I, Arnesen H, Tonstad S (2009)
Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: A 3-year intervention study
Nutr Metab Cardiovasc Dis, 19 (1), 8-14
PubMed 18472409

Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJ, LaRosa JC, Larsen ML, Lindahl C, Olsson AG, Tikkanen MJ, Waters DD, Pedersen TR, Steering Committees of IDEAL and TNT Trials (2009)
Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease
Am J Cardiol, 104 (4), 459-63
PubMed 19660594

Holme I, Strandberg TE, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)
Atherosclerosis, 205 (2), 522-7
PubMed 19327776

Holme I, Szarek M, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study
Eur J Cardiovasc Prev Rehabil, 16 (3), 315-20
PubMed 19322096

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Ann Med, 41 (7), 522-32
PubMed 19657769

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
Eur J Heart Fail, 11 (11), 1036-42
PubMed 19801574

Khoury J, Amundsen AL, Tonstad S, Henriksen T, Ose L, Retterstøl K, Iversen PO (2009)
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia
Acta Obstet Gynecol Scand, 88 (2), 222-6
PubMed 18972234

Kolsgaard ML, Wangensteen T, Brunborg C, Joner G, Holven KB, Halvorsen B, Aukrust P, Tonstad S (2009)
Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome
Scand J Clin Lab Invest, 69 (8), 858-64
PubMed 19929281

Liavaag AH, Tonstad S, Pripp AH, Tropé C, Dørum A (2009)
Prevalence and determinants of metabolic syndrome and elevated Framingham risk score in epithelial ovarian cancer survivors: a controlled observational study
Int J Gynecol Cancer, 19 (4), 634-40
PubMed 19509562

Malterud K, Tonstad S (2009)
Preventing obesity: challenges and pitfalls for health promotion
Patient Educ Couns, 76 (2), 254-9
PubMed 19157764

Michelsen TM, Pripp AH, Tonstad S, Tropé CG, Dørum A (2009)
Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study
Eur J Cancer, 45 (1), 82-9
PubMed 19008092

Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H, Assessment of Lescol in Renal Transplantation Study Group (2009)
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study
Arthritis Rheum, 60 (4), 1060-4
PubMed 19333947

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J, dal-OUTCOMES Committees and Investigators (2009)
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
Am Heart J, 158 (6), 896-901.e3
PubMed 19958854

Strandberg TE, Holme I, Faergeman O, Kastelein JJ, Lindahl C, Larsen ML, Olsson AG, Pedersen TR, Tikkanen MJ, IDEAL Study Group (2009)
Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction
Am J Cardiol, 103 (10), 1381-5
PubMed 19427432

Svendsen M, Helgeland M, Tonstad S (2009)
The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome
J Hum Nutr Diet, 22 (1), 55-63
PubMed 19192027

Tikkanen MJ, Holme I, Cater NB, Szarek M, Faergeman O, Kastelein JJ, Olsson AG, Larsen ML, Lindahl C, Pedersen TR, Incremental DEcrease through Aggressive Lipid Lowering Investigators (2009)
Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study)
Am J Cardiol, 103 (5), 577-82
PubMed 19231315

Tikkanen MJ, Szarek M, Fayyad R, Holme I, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Larsen ML, Lindahl C, Pedersen TR, IDEAL Investigators (2009)
Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial
J Am Coll Cardiol, 54 (25), 2353-7
PubMed 20082922

Tonstad S (2009)
Smoking cessation: how to advise the patient
Heart, 95 (19), 1635-40
PubMed 19752210

Tonstad S (2009)
Cigarette smoking, smoking cessation, and diabetes
Diabetes Res Clin Pract, 85 (1), 4-13
PubMed 19427049

Tonstad S (2009)
Practical implementation of varenicline as an aid to smoking cessation in clinical practice
Pneumologia, 58 (3), 167-74
PubMed 19817313

Tonstad S, Butler T, Yan R, Fraser GE (2009)
Type of vegetarian diet, body weight, and prevalence of type 2 diabetes
Diabetes Care, 32 (5), 791-6
PubMed 19351712

Tonstad S, Cowan JL (2009)
C-reactive protein as a predictor of disease in smokers and former smokers: a review
Int J Clin Pract, 63 (11), 1634-41
PubMed 19732183

Wangensteen T, Kolsgaard ML, Mattingsdal M, Joner G, Tonstad S, Undlien D, Retterstol L (2009)
Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway
Exp Clin Endocrinol Diabetes, 117 (6), 266-73
PubMed 19301229

Aasen G, Fagertun H, Tonstad S, Halse J (2009)
Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men
Scand J Clin Lab Invest, 69 (2), 181-9
PubMed 18937100